Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Glucagon-like peptide-1 (GLP-1) protects vascular endothelial cells against advanced glycation end products (AGEs)-induced apoptosis.

Zhan Y, Sun HL, Chen H, Zhang H, Sun J, Zhang Z, Cai DH.

Med Sci Monit. 2012 Jul;18(7):BR286-91.

2.

Glucagon-like peptide-1 counteracts the detrimental effects of Advanced Glycation End-Products in the pancreatic beta cell line HIT-T 15.

Puddu A, Storace D, Durante A, Odetti P, Viviani GL.

Biochem Biophys Res Commun. 2010 Jul 30;398(3):462-6. doi: 10.1016/j.bbrc.2010.06.100. Epub 2010 Jun 30.

PMID:
20599702
3.

Hepatocyte growth factor protects human endothelial cells against advanced glycation end products-induced apoptosis.

Zhou YJ, Wang JH, Zhang J.

Biochem Biophys Res Commun. 2006 Jun 2;344(2):658-66. Epub 2006 Apr 4.

PMID:
16630544
4.

Glucagon-like peptide-1 (GLP-1) inhibits advanced glycation end product (AGE)-induced up-regulation of VCAM-1 mRNA levels in endothelial cells by suppressing AGE receptor (RAGE) expression.

Ishibashi Y, Matsui T, Takeuchi M, Yamagishi S.

Biochem Biophys Res Commun. 2010 Jan 15;391(3):1405-8. doi: 10.1016/j.bbrc.2009.12.075. Epub 2009 Dec 22.

PMID:
20026306
5.

Sitagliptin augments protective effects of GLP-1 against advanced glycation end product receptor axis in endothelial cells.

Ishibashi Y, Matsui T, Takeuchi M, Yamagishi S.

Horm Metab Res. 2011 Sep;43(10):731-4. doi: 10.1055/s-0031-1284383. Epub 2011 Sep 19.

PMID:
21932180
6.

[Effect of GLP-1 on high glucose-induced human umbilical vein endothelial cell apoptosis and mechanism].

Yuan X, Chen K, He H, Zhao L, Mo Z.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2013 Oct;38(10):1029-34. doi: 10.3969/j.issn.1672-7347.2013.10.009. Chinese.

7.
8.

Glucagon-like peptide-1 attenuates advanced oxidation protein product-mediated damage in islet microvascular endothelial cells partly through the RAGE pathway.

Zhang Z, Yang L, Lei L, Chen R, Chen H, Zhang H.

Int J Mol Med. 2016 Oct;38(4):1161-9. doi: 10.3892/ijmm.2016.2711. Epub 2016 Aug 19.

9.

[Involvement of p38 MAPK pathway in GLP-1-induced inhibition of apoptosis in human umbilical vein endothelial cells].

Xu H, Li HL, Niu ZY, Li GZ, Cao J, Jiang YD.

Sheng Li Xue Bao. 2012 Aug 25;64(4):444-8. Chinese.

10.

Antiapoptotic effects of GLP-1 in murine HL-1 cardiomyocytes.

Ravassa S, Zudaire A, Carr RD, Díez J.

Am J Physiol Heart Circ Physiol. 2011 Apr;300(4):H1361-72. doi: 10.1152/ajpheart.00885.2010. Epub 2011 Jan 28.

PMID:
21278133
11.

Glucagon-like peptide-1 suppresses advanced glycation end product-induced monocyte chemoattractant protein-1 expression in mesangial cells by reducing advanced glycation end product receptor level.

Ishibashi Y, Nishino Y, Matsui T, Takeuchi M, Yamagishi S.

Metabolism. 2011 Sep;60(9):1271-7. doi: 10.1016/j.metabol.2011.01.010. Epub 2011 Mar 8.

PMID:
21388644
12.

Preventative effects of 4,4'-diphenylmethane-bis(methyl) carbamate isolated from cortex mori on human umbilical vein endothelial cell dysfunction induced by advanced glycation end products.

Feng L, Xu YH, Wang SS, Au-Yeung W, Zheng ZG, Wang RS, Zhu Q, Xiang P.

Phytother Res. 2012 Mar;26(3):412-9. doi: 10.1002/ptr.3569. Epub 2011 Jul 28.

PMID:
21796706
13.

Protective effects of hyperoside against human umbilical vein endothelial cell damage induced by hydrogen peroxide.

Li ZL, Liu JC, Hu J, Li XQ, Wang SW, Yi DH, Zhao MG.

J Ethnopharmacol. 2012 Jan 31;139(2):388-94. doi: 10.1016/j.jep.2011.11.020. Epub 2011 Nov 23.

PMID:
22120016
14.

A PKC-beta inhibitor prompts the HUVECs apoptosis-induced by advanced glycation end products.

Wang SS, Xu YH, Feng L, Zhu Q, He B.

Pharmazie. 2011 Nov;66(11):881-7.

PMID:
22204135
15.

[Role of p38MAPK/eNOS signaling pathway in the inhibition of AGEs-induced apoptosis of human umbilical vein endothelial cells by glucagon-like peptide-1].

Zeng H, Huang Z, Zhang Y, Sun H.

Nan Fang Yi Ke Da Xue Xue Bao. 2016 Jan;36(1):116-9, 139. Chinese.

PMID:
26806750
16.

Glucagon-like peptide-1 activates endothelial nitric oxide synthase in human umbilical vein endothelial cells.

Ding L, Zhang J.

Acta Pharmacol Sin. 2012 Jan;33(1):75-81. doi: 10.1038/aps.2011.149. Epub 2011 Nov 28.

17.

Glucose-dependent insulinotropic polypeptide (GIP) inhibits signaling pathways of advanced glycation end products (AGEs) in endothelial cells via its antioxidative properties.

Ojima A, Matsui T, Maeda S, Takeuchi M, Yamagishi S.

Horm Metab Res. 2012 Jun;44(7):501-5. doi: 10.1055/s-0032-1312595. Epub 2012 May 11.

PMID:
22581648
18.

New role of JAK2/STAT3 signaling in endothelial cell oxidative stress injury and protective effect of melatonin.

Duan W, Yang Y, Yi W, Yan J, Liang Z, Wang N, Li Y, Chen W, Yu S, Jin Z, Yi D.

PLoS One. 2013;8(3):e57941. doi: 10.1371/journal.pone.0057941. Epub 2013 Mar 6.

19.

The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.

Ligumsky H, Wolf I, Israeli S, Haimsohn M, Ferber S, Karasik A, Kaufman B, Rubinek T.

Breast Cancer Res Treat. 2012 Apr;132(2):449-61. doi: 10.1007/s10549-011-1585-0. Epub 2011 Jun 3.

PMID:
21638053
20.

Hepatocyte growth factor prevents advanced glycation end products-induced injury and oxidative stress through a PI3K/Akt-dependent pathway in human endothelial cells.

Zhou YJ, Yang HW, Wang XG, Zhang H.

Life Sci. 2009 Nov 4;85(19-20):670-7. doi: 10.1016/j.lfs.2009.09.006. Epub 2009 Sep 22.

PMID:
19778541

Supplemental Content

Support Center